אירינוטקן אקטביס 20 מ"ג/מ"ל - Irinotecan actavis 20mg/ml
ש××× ×× !
×תר××¤× × ×¢××× ×:×××ר ×תר×פ×ת ×©× ××©×¨× ××ר×××ת.
×× ×תק××× ××××¢× ×¢× ×פסקת ש×××ק ×תר××¤× ×:×ער×ת ×××××¢×ת ×¢× ×פסקת ש×××ק תר×פ×ת.
ת×ר×× ×¢×××× ××ר×× ×תר××¤× ×× ×××ק×תר×פ×ת ××× 14/05/19.
×תר××¤× × ×¢××× ×:×××ר ×תר×פ×ת ×©× ××©×¨× ××ר×××ת.
×× ×תק××× ××××¢× ×¢× ×פסקת ש×××ק ×תר××¤× ×:×ער×ת ×××××¢×ת ×¢× ×פסקת ש×××ק תר×פ×ת.
ת×ר×× ×¢×××× ××ר×× ×תר××¤× ×× ×××ק×תר×פ×ת ××× 14/05/19.
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | ||||||
|---|---|---|---|---|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | L01CE Topoisomerase 1 (TOP1) inhibitors | |||||
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||
| צ×רת ××ª× | ת××-×ר××× - I.V | |||||
| צ×רת ××× ×× | תר××× ×××× ×ª ת×××¡× ×××× ×¤××××, CONCENTRATE FOR SOLUTION FOR INFUSION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||
| ×ת×××× | For the treatment of patients with metastatic colorectal cancer: In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen. For the treatment of patients with small cell lung cancer. For the treatment of patients with gastric cancer.
| |||||
× ×ª×× × ×¡× [ ×צ×× ]
| ||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
××× ×¢××× ×ר××¤× | |||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| [ ××ר×× ×××§× ×ק×××ס 20 ×"×/×"×] ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | ACTAVIS GROUP PTC EHF, ICELAND |
| ×©× ××¢× ×ר×ש×× | ABIC MARKETING LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 10/2012. ר×ש××× ×ת×ר××: 11/2015 |
| ת×ר×× ×¢×××× ××ר×× | 14/05/19 |